Close Menu

NEW YORK – Inivata said today that it has signed a distribution agreement with IPS Genomix to provide its InVisionFirst-Lung and InVisionSeq liquid biopsy tests to cancer patients and partners in the Middle East and Africa.

Under the agreement, IPS Genomix — a part of Integrated Pharma Solutions — will facilitate patient access through both insurers and in the private pay market in the United Arab Emirates, Qatar, Kuwait, Bahrain, Lebanon, Jordan, Egypt, and the Kingdom of Saudi Arabia.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
03

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.